Home > PE Ratio > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of SHUKRA PHARMACEUTICALS is 60.50.

Share Price ₹30.3May 18,2026
Market Cap ₹1,333.7 Cr
Earnings-TTM₹22.0 CrTTM-Standalone Results
Price/Earnings60.50xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SHUKRA PHARMACEUTICALS
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of SHUKRA PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SHUKRA PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹1,333.7 Cr] as on May 18,2026

(/) Earnings [ ₹22.0 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 60.50x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SHUKRA PHARMACEUTICALS , the investors are currently willing to pay 60.50 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SHUKRA PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SHUKRA PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of SHUKRA PHARMACEUTICALS


PE Ratio Performance Analysis for SHUKRA PHARMACEUTICALS

- SHUKRA PHARMACEUTICALS 's latest p/e ratio is 60.50x.

- SHUKRA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 22.35x.

- SHUKRA PHARMACEUTICALS 's operated at median p/e ratio of 2.62x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SHUKRA PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 99.91x.

- SHUKRA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0.48x.


How does SHUKRA PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SHUKRA PHARMACEUTICALS 22.0560.501,333.7
SUN PHARMACEUTICAL INDUSTRIES LTD11,001.4041.55457,121.0
DIVIS LABORATORIES LTD2,479.0073.17181,396.0
CIPLA LTD3,869.7929.78115,241.0
TORRENT PHARMACEUTICALS LTD2,272.0065.46148,730.0
DR REDDYS LABORATORIES LTD4,144.2026.81111,126.0
MANKIND PHARMA LTD1,796.6557.36103,056.0
ZYDUS LIFESCIENCES LTD4,933.9020.2199,737.9
LUPIN LTD5,355.4719.23103,011.0
AUROBINDO PHARMA LTD3,513.2024.5986,401.6
ABBOTT INDIA LTD1,552.0238.2459,344.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SHUKRA PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.23x
Max industry PE 73.17x
Median industry PE 38.24x
Average industry PE 41.54x



You may also like the below Video Courses